Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research

Extracellular vesicles (EVs) are secreted, cell-derived, membrane-bound compartments implicated in various diseases for their ability to influence distant targets and as carriers of biomarkers. Here, we present a protocol for separating EVs from mammalian pancreatic cancer cells and their characterization using western blot and electron microscopy. We then demonstrate how they are utilized to affect tumor development in a murine model of metastatic pancreatic cancer including a method to quantify hepatic tumor burden in histologic samples. For complete details on the use and execution of this protocol, please refer to Dudgeon et al.<sup>1</sup>.

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2024-08-13
DOI
https://doi.org/10.1016/j.xpro.2024.103256
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research

Crissy Dudgeon, Mélanie Bellina, Darren R. Carpizo, Wade C. Narrow et al.
STAR Protocols
Extracellular vesicles in disease
article

Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research

Crissy Dudgeon, Mélanie Bellina, Darren R. Carpizo, Wade C. Narrow, Muhammad Sadeqi Nezhad, Orjola Prela, Anthony Casabianca, Chris Harris, Stephany Fiore, Patrick Mehlen, Igor Astsaturov, Lan Wang, Agnès Bernet
article en

Abstract

Extracellular vesicles (EVs) are secreted, cell-derived, membrane-bound compartments implicated in various diseases for their ability to influence distant targets and as carriers of biomarkers. Here, we present a protocol for separating EVs from mammalian pancreatic cancer cells and their characterization using western blot and electron microscopy. We then demonstrate how they are utilized to affect tumor development in a murine model of metastatic pancreatic cancer including a method to quantify hepatic tumor burden in histologic samples. For complete details on the use and execution of this protocol, please refer to Dudgeon et al.<sup>1</sup>.

STAR ProtocolsVol. 5(3)
Université Claude Bernard Lyon 1 (FR), Rutgers, The State University of New Jersey (US), Fox Chase Cancer Center (US), Centre National de la Recherche Scientifique (FR), Inserm (FR), University of Rochester Medical Center (US), Netris Pharma (France) (FR), Centre de Recherche en Cancérologie de Lyon (FR), Rutgers Cancer Institute (US), University of Rochester (US)
Pancreatic Cancer Action Network, Agence Nationale de la Recherche, Ligue Contre le Cancer, Institut National Du Cancer
Openalex Percentile: Top 88%
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.